Summary
Aberrant DNA methylation is one of the major characteristics of tumor cells in addition to genetic and other epigenetic alterations. Evidence shows that both regional hypermethylation and global hypomethylation can occur in cancer cells. Increased DNA methylation can be found at select tumor-suppressor gene promoters, causing the silencing of these genes in tumorigenic cells. At the same time, a global decrease in DNA methylation is frequently observed in cancer cells, which may contribute to genome instability. Unlike genetic mutations, hypermethylation at tumor-suppressor gene promoters can be reversed with epigenetic therapy by using DNA demethylating agents.
To better understand the mechanisms of cancer initiation and progression, and to better assess the effects of epigenetic therapy, a reliable high-throughput method for genome-wide DNA methylation analysis is needed. Recently, the process of coupling methylated DNA immunoprecipitation (mDIP) with microarray hybridization has been proven to be a successful strategy to map genome-wide DNA methylation patterns in different cell types.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Robertson, K.D. and Wolffe, A.P. (2000) DNA methylation in health and disease. Nature reviews, 1, 11–9.
Bestor, T.H. (2000) The DNA methyltransferases of mammals. Human molecular genetics, 9, 2395–402.
Jones, P.A. and Laird, P.W. (1999) Cancer epigenetics comes of age. Nature genetics, 21, 163–7.
Costello, J.F., Fruhwald, M.C., Smiraglia, D.J., Rush, L.J., Robertson, G.P., Gao, X., Wright, F.A., Feramisco, J.D., Peltomaki, P., Lang, J.C., et al. (2000) Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nature genetics, 24, 132–8.
Feinberg, A.P. and Vogelstein, B. (1983) Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature, 301, 89–92.
Claus, E.B., Petruzella, S., Matloff, E. and Carter, D. (2005) Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ. The Journal of the American Medical Association, 293, 964–9.
Aaltonen, L.A., Salovaara, R., Kristo, P., Canzian, F., Hemminki, A., Peltomaki, P., Chadwick, R.B., Kaariainen, H., Eskelinen, M., Jarvinen, H., et al. (1998) Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. The New England journal of medicine, 338, 1481–7.
Feinberg, A.P., Ohlsson, R. and Henikoff, S. (2006) The epigenetic progenitor origin of human cancer. Nature reviews, 7, 21–33.
Eckhardt, F., Lewin, J., Cortese, R., Rakyan, V.K., Attwood, J., Burger, M., Burton, J., Cox, T.V., Davies, R., Down, T.A., et al. (2006) DNA methylation profiling of human chromosomes 6, 20 and 22. Nature genetics, 38, 1378–85.
Meissner, A., Gnirke, A., Bell, G.W., Ramsahoye, B., Lander, E.S. and Jaenisch, R. (2005) Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis. Nucleic acids research, 33, 5868–77.
Weber, M., Davies, J.J., Wittig, D., Oakeley, E.J., Haase, M., Lam, W.L. and Schubeler, D. (2005) Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nature genetics, 37, 853–62.
Zhang, X., Clarenz, O., Cokus, S., Bernatavichute, Y.V., Pellegrini, M., Goodrich, J. and Jacobsen, S.E. (2007) Whole-genome analysis of histone H3 lysine 27 trimethylation in Arabidopsis. PLoS biology, 5, e129.
Zilberman, D., Gehring, M., Tran, R.K., Ballinger, T. and Henikoff, S. (2007) Genome-wide analysis of Arabidopsis thaliana DNA methylation uncovers an interdependence between methylation and transcription. Nature genetics, 39, 61–9.
Zhang, X., Yazaki, J., Sundaresan, A., Cokus, S., Chan, S.W., Chen, H., Henderson, I.R., Shinn, P., Pellegrini, M., Jacobsen, S.E., et al. (2006) Genome-wide high-resolution mapping and functional analysis of DNA methylation in arabidopsis. Cell, 126, 1189–201.
Keshet, I., Schlesinger, Y., Farkash, S., Rand, E., Hecht, M., Segal, E., Pikarski, E., Young, R.A., Niveleau, A., Cedar, H., et al. (2006) Evidence for an instructive mechanism of de novo methylation in cancer cells. Nature genetics, 38, 149–53.
Weber, M., Hellmann, I., Stadler, M.B., Ramos, L., Paabo, S., Rebhan, M. and Schubeler, D. (2007) Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nature genetics, 39, 457–66.
Clark, S.J., Harrison, J., Paul, C.L. and Frommer, M. (1994) High sensitivity mapping of methylated cytosines. Nucleic acids research, 22, 2990–7.
Herman, J.G., Latif, F., Weng, Y., Lerman, M.I., Zbar, B., Liu, S., Samid, D., Duan, D.S., Gnarra, J.R., Linehan, W.M., et al. (1994) Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proceedings of the National Academy of Sciences of the United States of America, 91, 9700–4.
Cameron, E.E., Baylin, S.B. and Herman, J.G. (1999) p15(INK4B) CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing. Blood, 94, 2445–51.
Acknowledgments
We thank Dr. Howard Cedar at Hebrew University and Drs. Xiaoyu Zhang and Steve Jacobsen at UCLA for sharing with us their technical notes. Funding support for this work is from National Institutes of Health.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Shen, Y., Fouse, S.D., Fan, G. (2009). Genome-Wide DNA Methylation Profiling: The mDIP-Chip Technology. In: Yu, J. (eds) Cancer Stem Cells. Methods in Molecular Biology, vol 568. Humana Press. https://doi.org/10.1007/978-1-59745-280-9_13
Download citation
DOI: https://doi.org/10.1007/978-1-59745-280-9_13
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-58829-938-3
Online ISBN: 978-1-59745-280-9
eBook Packages: Springer Protocols